This is a randomised, double-blind, placebo-controlled Phase 3 registration parallel arm study to evaluate the efficacy, safety and tolerability of 60 mg Promethean Health CBD daily vs. placebo in adults experiencing mild-to-moderate pain.
This study is being conducted at our Western Sydney, Canberra, Central Coast and Brisbane sites.
Apply Now
A 21-week study investigating whether combining semaglutide with CBD as an oral treatment can improve metabolic health in overweight individuals with Type 2 Diabetes or prediabetes.
This study is being conducted at our Brisbane and Western Sydney clinics.
Apply Now
A Phase 1 study to investigate the safety and immunogenicity of an adjuvanted RSV/hMPV mRNA vaccine in adult participants aged 60 to 75 years.
This study is being conducted at our Brisbane site.
Apply Now
